Neostigmine1 (Neostigmine1)
Neostigmine Methylsulfate Injection
Product Images NDC 65145-112
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Neostigmine Methylsulfate (NDC 65145-112). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Caplin Steriles Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Image2 (Neostigmine2)
This is a description of Neostigmine injection, an intravenous drug that is manufactured by Caplin Steriles Limited in India. The drug is stored in a 10mL multiple dose vial, protected from light, and should be kept at 20° to 25°C until use. Each mL of the sterile solution contains Neostigmine, Phencl, Sod N, and Wethysulate. The pH is adjusted with Sodium Hydroxide/AceticAcd, and the drug should be used as directed in the package insert.*
Image3 (Neostigmine3)
This is a description for a medication called Neostigmine Methylsulfate Injection, USP. The medication is provided in 10x10 mL multiple dose vials and is meant for intravenous use. The vials contain 5 mg of the medication per 10 mL (0.5 mg/mL). The product is only available with a prescription and is manufactured by Caplin Steres. The other numbers and text do not provide any additional useful information for the description.*
Image4 (Neostigmine4)
The text describes the details of a medication called Neostigmine Methylsulfate Injection, USP which is available in a 10x10mL Multiple Dose Vials. The medicine is intended to be used only via the intravenous route. The package contains Neostigmine Methylsulfate Injection of strength 5mg/10mL, mixed with other chemicals like Phenol and Sodium Acetate Tryrat. The directions for use are specified. The medicine should be stored between 20°C to 25°C and should be protected from light until the time of use.*
Image5 (Neostigmine5)
Neostigmine Methylsulfate Injection, USP is a medication that contains 1 mg of Neostigmine Methylsulfate, 4.5 mg of Phenol (as a preservative), 0.2 mg of Sodium Acetate Tritydrate, and Water for Injection. Sodium Hydroxide and Acetic Acid are used to adjust the pH level. It is stored at 20° to 25°C and protected from light until it is time for use. It comes in a 10 mL multiple-dose vial and is for intravenous use. The medication is manufactured by Caplin Steriles Limited in India. More information can be found in the package insert.*
Image6 (Neostigmine6)
This is a product label for Neostigmine Methylsulfate Injection, a medicine available in a 10mg/mL concentration. It is intended for intravenous use and is packaged in multiple dose vials of 10x10ml. The product is manufactured by a company named Capn Stris i.*
Image7 (Neostigmine7)
The text includes a measurement of 58.00 mm, and some illegible characters such as "wussiL|", "Neostigmine", "Methylsulfate Injection, USP" with a dosage of 10 mg/10 m, and prescription information for intravenous use. The text also mentions a "MulileDoseVals" of 1010 mL, a warning for "RxOnly", and some additional unclear information about direction and control.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
